Arabic Arabic English English French French German German
dark

AzurRx BioPharma Announces Reverse Stock SplitCommon Stock Will Begin Trading on Split-Adjusted Basis on September 13, 2021

AzurRx BioPharma, Inc. announced today that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Neutrophil immunomodulatory activity of natural organosulfur compounds.

Next Post

Poxel Announces Product Launch in Japan for TWYMEEG® as Treatment for Type 2 Diabetes

Related Posts
Total
0
Share